Report Detail
(Post-pandemic Era)-Global Molecular Diagnostics in Infectious Disease Testing Market Segment Research Report 2022
- RnM4478079 |
- 04 August, 2022 |
- Global |
- 111 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Molecular Diagnostics in Infectious Disease Testing Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Molecular Diagnostics in Infectious Disease Testing industry at home and abroad, estimate the overall market scale of the Molecular Diagnostics in Infectious Disease Testing industry and the market share of major countries, Molecular Diagnostics in Infectious Disease Testing industry, and study and judge the downstream market demand of Molecular Diagnostics in Infectious Disease Testing through systematic research, Analyze the competition pattern of Molecular Diagnostics in Infectious Disease Testing, so as to help solve the pain points of various stakeholders in Molecular Diagnostics in Infectious Disease Testing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Molecular Diagnostics in Infectious Disease Testing Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Molecular Diagnostics in Infectious Disease Testing Market?
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Major Type of Molecular Diagnostics in Infectious Disease Testing Covered in XYZResearch report:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Application Segments Covered in XYZResearch Market
Hospitals
Clinics
Academic Institutes
Laboratories
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Molecular Diagnostics in Infectious Disease Testing Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Molecular Diagnostics in Infectious Disease Testing Market by Value
- 2.2.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Type
- 2.2.2 Global Molecular Diagnostics in Infectious Disease Testing Market by Value (%)
- 2.3 Global Molecular Diagnostics in Infectious Disease Testing Market by Production
- 2.3.1 Global Molecular Diagnostics in Infectious Disease Testing Production by Type
- 2.3.2 Global Molecular Diagnostics in Infectious Disease Testing Market by Production (%)
3. The Major Driver of Molecular Diagnostics in Infectious Disease Testing Industry
- 3.1 Historical & Forecast Global Molecular Diagnostics in Infectious Disease Testing Demand
- 3.2 Largest Application for Molecular Diagnostics in Infectious Disease Testing (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Molecular Diagnostics in Infectious Disease Testing Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Molecular Diagnostics in Infectious Disease Testing Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Molecular Diagnostics in Infectious Disease Testing Average Price Trend
- 12.1 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in US (2018-2022)
- 12.2 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Europe (2018-2022)
- 12.3 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in China (2018-2022)
- 12.4 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Japan (2018-2022)
- 12.5 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in India (2018-2022)
- 12.6 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Korea (2018-2022)
- 12.7 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Molecular Diagnostics in Infectious Disease Testing Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Molecular Diagnostics in Infectious Disease Testing
14. Molecular Diagnostics in Infectious Disease Testing Competitive Landscape
- 14.1 Abbott
- 14.1.1 Abbott Company Profiles
- 14.1.2 Abbott Product Introduction
- 14.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 BD
- 14.2.1 BD Company Profiles
- 14.2.2 BD Product Introduction
- 14.2.3 BD Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 BioMerieux
- 14.3.1 BioMerieux Company Profiles
- 14.3.2 BioMerieux Product Introduction
- 14.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Thermo Fisher Scientific
- 14.4.1 Thermo Fisher Scientific Company Profiles
- 14.4.2 Thermo Fisher Scientific Product Introduction
- 14.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Roche
- 14.5.1 Roche Company Profiles
- 14.5.2 Roche Product Introduction
- 14.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Siemens
- 14.6.1 Siemens Company Profiles
- 14.6.2 Siemens Product Introduction
- 14.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Veridex
- 14.7.1 Veridex Company Profiles
- 14.7.2 Veridex Product Introduction
- 14.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Luminex
- 14.8.1 Luminex Company Profiles
- 14.8.2 Luminex Product Introduction
- 14.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 GenMark Diagnostics
- 14.9.1 GenMark Diagnostics Company Profiles
- 14.9.2 GenMark Diagnostics Product Introduction
- 14.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Qiagen
- 14.10.1 Qiagen Company Profiles
- 14.10.2 Qiagen Product Introduction
- 14.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
- 14.11 Genomix Biotech
- 14.12 BioTheranostics
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Molecular Diagnostics in Infectious Disease Testing. Industry analysis & Market Report on Molecular Diagnostics in Infectious Disease Testing is a syndicated market report, published as (Post-pandemic Era)-Global Molecular Diagnostics in Infectious Disease Testing Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Molecular Diagnostics in Infectious Disease Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
